Target intelligence / Profile preview

Tetrodotoxin-resistant voltage-gated sodium channels (TTX-R VGSCs)

Target
TTX-R VGSCs
Molecular classification
Ion channel, Voltage-gated sodium channel, Transmembrane protein
01

Overview

Tetrodotoxin-resistant (TTX-R) voltage-gated sodium channels, primarily comprising the Nav1.8 (SCN10A) and Nav1.9 (SCN11A) isoforms, are critical mediators of excitability in peripheral sensory neurons [PMID: 23333502]. These channels are predominantly expressed in the dorsal root ganglion (DRG) and trigeminal ganglion, where they play a fundamental role in the initiation and propagation of action potentials in nociceptors [PMID: 24021961]. Unlike TTX-sensitive channels, Nav1.8 and Nav1.9 exhibit distinct kinetic properties, such as slow inactivation, which allow them to support repetitive firing during sustained noxious stimuli or inflammatory states [PMID: 10433265]. Their restricted expression in the peripheral nervous system makes them highly attractive therapeutic targets for treating chronic pain conditions, such as neuropathic and inflammatory pain, with a reduced risk of central nervous system or cardiac side effects [PMID: 38570519]. Recent clinical developments, such as the selective Nav1.8 inhibitor suzetrigine (VX-548), have demonstrated the potential for these channels to provide effective analgesia without the addictive properties or respiratory risks associated with opioids [Vertex Pharmaceuticals, 2024].

Other names
Nav1.8Nav1.9SCN10ASCN11ASodium channel protein type 10 subunit alphaSodium channel protein type 11 subunit alphaPeripheral nerve-type 3 (PN3)Sensory neuron-specific (SNS) sodium channelNaN (Sodium channel alpha-subunit Next)
02

Mechanism of action

Blockade of the alpha-subunit pore of Nav1.8 and Nav1.9 channels, which prevents the influx of sodium ions required for membrane depolarization, thereby inhibiting the generation and conduction of pain-related action potentials in peripheral sensory neurons [PMID: 23333502].

03

Biological functions

NociceptionAction potential generationSensory transductionRegulation of neuronal excitability
04

Disease associations

Neuropathic painInflammatory painSmall fiber neuropathyErythromelalgiaPruritus
05

Safety considerations

Cardiac arrhythmia (due to potential Nav1.5 cross-reactivity)ParesthesiaDizzinessLocalized numbness
06

Interacting drugs

Suzetrigine (VX-548)

5 more in the full profile.

07

Biomarkers

Visual Analog Scale (VAS) scoreNumeric Rating Scale (NRS)Intraepidermal nerve fiber density (IENFD)Quantitative sensory testing (QST)

Beyond the preview

Go deeper on Tetrodotoxin-resistant voltage-gated sodium channels (TTX-R VGSCs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetrodotoxin-resistant voltage-gated sodium channels (TTX-R VGSCs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call